Implantation of the cell product UroArt™ is endoscopic and conducted in a hospital Outpatients. The autologous source of cells and scaffold excludes the possibility of implant rejection. The use of autologous cell products avoids the danger of transmitting infectious diseases. Autologous cartilage cells form live, patient’s own tissue, which consolidates at the site of injection and, with time, grows and strengthens the ureteral orifice – the treatment is thus permanent.
With such a treatment of VUR, it is possible for the patient to keep their own kidney, avoiding the need for kidney transplantation. The patient’s own kidney still has a very important endocrine function because of the effect on bone marrow and blood cell formation.
With such a treatment of VUR, it is possible for the patient to keep their own kidney, avoiding the need for kidney transplantation. The patient’s own kidney still has a very important endocrine function because of the effect on bone marrow and blood cell formation.